Immuron Limited
IMRNNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $7.09M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.68$2.35
- Volume (live)
- -
- Avg. volume (3M)
- 77.67K
Immuron (IMRN) Stock Price & Financial Analysis
Immuron Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.93 - $0.99 |
|---|---|
| 52-Week High | $2.35 |
| 52-Week Low | $0.68 |
| Open | $0.93 |
| Volume (last close) | 7.11K |
| Average Volume (3M) | 77.67K |
| Revenue (TTM) | 8.88M |
|---|---|
| Net Income (TTM) | -5.60M |
| Free Cash Flow (TTM) | -4.52M |
| EPS (TTM) | −$0.84 |
| Profit Margin | -63.03% |
| Operating Margin | -71.07% |
| Return on Equity (ROE) | -71.28% |
| Debt to Equity | 0.00 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 7.09M |
|---|---|
| Shares Outstanding | 7.44M |
| Price to Sales (P/S) | 0.80 |
| Price to Book (P/B) | 0.90 |
| EV/EBITDA | -0.12 |
| 50-Day MA | $1.19 |
|---|---|
| 200-Day MA | $1.02 |
| 1-Year Change | −56.05% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Immuron at a Glance
As of the Oct 23, 2026 close, Immuron (IMRN) has a market capitalization of $7.09M. The stock trades at 0.8× sales. Over the trailing twelve months it lost $5.60M on revenue of $8.88M and burned $4.52M of free cash flow. Revenue grew 28.7% year over year.
As of its latest reported balance sheet, it holds $6.34M in cash and securities against $0.00 of debt, a net cash position of $6.34M.
Immuron does not currently pay a dividend.
The share price is down 56.1% over the past year. At $0.95 (the Oct 23, 2026 close) it sits within its 52-week range of $0.68 to $2.35, below its 200-day moving average of $1.02.
Frequently Asked Questions About Immuron
What is the current stock price for IMRN?
As of the Oct 23, 2026 close, IMRN stock trades at $0.95. The 52-week range is $0.68–$2.35, with a day range of $0.93–$0.99.
What is the P/E ratio for IMRN?
The P/E ratio (Price-to-Earnings) for IMRN is shown in the Key Statistics section. This valuation metric helps compare Immuron Limited to industry peers.
Does IMRN pay dividends?
Immuron does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for IMRN?
Analyst ratings and recommendations for IMRN are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of IMRN?
As of the Oct 23, 2026 close, Immuron's market capitalization is $7.1M, classifying it as a micro-cap company. Immuron operates in the Healthcare sector within the Biotechnology industry.